Why the study?
The choice between single-coil and dual-coil ICD leads can influence device performance and patient outcomes, requiring evaluation to inform clinical decision-making.
Do single-coil ICD leads improve clinical outcomes and device performance compared to dual-coil ICD leads in patients at risk of ventricular arrhythmias?
Do single-coil ICD leads improve clinical outcomes and device performance compared to dual-coil ICD leads in patients at risk of ventricular arrhythmias?
Single-coil ICD leads may offer superior first-shock efficacy and reduced all-cause mortality compared to dual-coil leads, supporting their use in appropriate patients.
Answers are grounded in this paper and cite their sources.
Favors single-coil ICD leads for better shock efficacy and survival; extends RCT evidence supporting simplified leads in practice.
Background Implantable cardioverter-defibrillators (ICDs) are essential for reducing sudden cardiac death in patients at risk of ventricular arrhythmias. The choice of ICD lead – single-coil or dual-coil – can influence device performance and patient outcomes. This meta-analysis evaluates the comparative efficacy and safety of single-coil versus dual-coil ICD leads to inform clinical decision-making.Methods A systematic search of PubMed, Cochrane Library, and Google Scholar was performed up to October 2024. Only randomized controlled trials (RCTs) comparing single-coil and dual-coil ICD leads were included. Outcomes assessed included defibrillation threshold (DFT), first-shock efficacy, all-cause mortality, cardiovascular mortality, shock impedance, and peak current.Results Seven RCTs involving 1,614 patients were analyzed. Single-coil leads demonstrated superior first-shock efficacy (OR: 1.60; p = 0.05), reduced all-cause mortality (RR: 0.63; p = 0.02), and better peak current (MD: −2.29; p = 0.02). DFT and cardiovascular mortality were comparable between groups, while dual-coil leads exhibited lower shock impedance (MD: 18.26; p < 0.00001).Conclusions Single-coil ICD leads are associated with improved first-shock efficacy and reduced all-cause mortality, suggesting their potential superiority in certain patient populations. Further research is warranted to refine lead selection criteria.
No takes yet. Share an insight, caveat, or question.
Shuja et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: